TB-500 and TB-500 Fragment sourcing should begin with naming and sequence clarification, not price comparison. In B2B procurement, the main risk is that different suppliers may use similar names while referring to different sequence references, material forms, documentation packages, or quote units.
A common buyer mistake is asking for “TB-500 price” without confirming whether the supplier is quoting TB-500, a TB-500 fragment, or another related sequence reference. If the sequence, CAS reference where applicable, molecular weight, salt form, and documentation scope are not defined, supplier quotes are not yet comparable.
This guide is written for distributors, private label brand owners, OEM project teams, formulation consultants, and procurement buyers evaluating TB-500 or TB-500 Fragment in bulk powder, lyophilized vial, or custom fill project formats.
It is a B2B sourcing and specification reference. It does not provide end-user application guidance, biological-effect discussion, clinical recommendations, or outcome claims.
What TB-500 / TB-500 Fragment Is from a Sourcing Perspective
From a sourcing perspective, TB-500 should be reviewed as a naming-sensitive peptide procurement project. The exact material definition must be confirmed before price, MOQ, or documentation can be evaluated.
In supplier catalogs, buyers may encounter terms such as:
- TB-500.
- TB-500 Fragment.
- Thymosin Beta-4-related sequence references.
- Shorter fragment naming used by different suppliers.
These names should not be treated as automatically interchangeable. Buyers should confirm the exact amino acid sequence or supplier specification reference behind the quoted product.
A serious B2B review should clarify:
- Product name used by the supplier.
- Exact sequence reference.
- CAS number where applicable.
- Molecular formula and molecular weight.
- Salt form or counterion where relevant.
- Physical form.
- Batch number once allocated.
- Bulk powder or lyophilized vial format.
- Documentation package.
The sourcing question is not only whether a supplier lists “TB-500.” The real question is whether the supplier can define exactly what it is offering and support that definition with batch-linked documentation.
Why TB-500 Sourcing Projects Stall and How to Avoid It
TB-500 sourcing projects often stall because the buyer and supplier are using the same name but not the same specification.
Common buyer mistakes at the start of a project
Common early mistakes include:
- Requesting a quote without specifying TB-500 vs. TB-500 Fragment.
- Assuming all suppliers use the same sequence reference.
- Comparing prices before receiving a specification sheet.
- Accepting a USD/vial quote without fill amount.
- Treating a catalog listing as proof of current stock.
- Not asking whether documentation is batch-specific.
- Not clarifying salt form or counterion where relevant.
- Accepting lead time as one total number without scope.
- Requesting custom vial format before defining fill amount and packaging scope.
These mistakes usually lead to repeated clarification emails, delayed quotation, or supplier comparisons that look precise but are actually based on different product definitions.
What to clarify before comparing quotes
Before comparing TB-500 suppliers, buyers should clarify:
- Exact product name and sequence reference.
- Whether the supplier is quoting TB-500 or a fragment.
- CAS number where applicable.
- Molecular weight reference.
- Salt form or counterion where relevant.
- Required format: bulk powder, lyophilized vial, or custom fill.
- Target quantity or fill amount.
- Quote basis: USD/g, USD/mg, USD/vial, or USD/box.
- Purity method and threshold.
- Documentation package.
- MOQ basis.
- Lead time scope.
- Packaging and labeling requirements.
- Destination-market shipment requirements.
If two suppliers cannot answer these questions in the same structure, their prices are not yet comparable.
For unit comparison logic, see WUMO's guide: Peptide Quote Units Explained: USD/g vs USD/vial vs USD/box.
TB-500 Naming and Sequence Ambiguity Buyers Must Clarify
The most important sourcing issue for TB-500 is naming ambiguity. A label or catalog name is not enough.
The naming problem
“TB-500” is widely used as a market-facing label, but B2B buyers should not rely on the label alone. Depending on the supplier, the quoted material may be described as TB-500, TB-500 Fragment, or a sequence associated with a broader Thymosin Beta-4 reference.
Different suppliers may use the same label for different sequence references. That creates real procurement risk if the buyer compares price without first confirming the specification.
A buyer should not ask only:
What is your TB-500 price?
A stronger sourcing question is:
Please confirm the exact sequence, CAS reference where applicable, molecular weight, salt form, purity method, and documentation package for the TB-500 or TB-500 Fragment you are quoting.
Checklist before proceeding
Before accepting a quotation, buyers should confirm:
- Exact amino acid sequence or supplier sequence reference.
- Applicable CAS number where available.
- Molecular formula.
- Molecular weight.
- Salt form or counterion where applicable.
- Physical form.
- Purity threshold.
- Analytical method.
- Whether documentation is representative or batch-specific.
- Whether the supplier uses TB-500 and TB-500 Fragment consistently across documents.
If the specification sheet and COA do not clearly define the material, the quotation should not be treated as final.
TB-500 Specification Fields Every B2B Buyer Should Review
A specification sheet should define what is being quoted. Without it, buyers may be comparing different materials under similar names.
Core specification fields
Key fields include:
- Product name.
- Sequence reference.
- CAS number where applicable.
- Molecular formula.
- Molecular weight.
- Salt form or counterion.
- Physical appearance.
- Purity threshold.
- Analytical method.
- Water content where applicable.
- Residual solvent limits where applicable.
- Storage condition.
- Packaging format.
- Shelf-life or retest statement where available.
The specification sheet should align with the COA and analytical reports. If the specification sheet says one thing and the COA uses another naming convention, buyers should request clarification before proceeding.
Why each field matters
Sequence and CAS confirmation help prevent substitution or misunderstanding. Salt form can affect molecular weight reference and cost comparison. Purity method affects whether two supplier quotes can be compared. Storage and shipment fields affect project planning.
The goal is not to collect documents for formality. The goal is to make sure the buyer, supplier, and downstream review team are discussing the same material.
Documentation: What to Request, When, and Why
Documentation should be requested before the buyer commits to a first order. It is part of supplier qualification, not only a shipment attachment.
Standard document package
A practical TB-500 / TB-500 Fragment documentation package may include:
- Batch-specific COA.
- HPLC chromatogram.
- LC-MS or mass confirmation where available.
- SDS.
- Specification sheet.
- Batch number reference.
- Packing list.
- Commercial invoice.
- Storage and handling statement.
The COA should show batch number, issue date, purity result, test method, appearance, and relevant batch fields. The HPLC report should support the purity figure. LC-MS, where available, helps support molecular identity review. SDS supports shipment and handling review.
The most important issue is consistency. Product name, sequence reference, batch number, and material identity should align across documents.
When to request each document
At supplier qualification stage, buyers should request:
- Specification sheet.
- Representative or batch-specific COA.
- HPLC report.
- LC-MS availability statement.
- SDS.
Before shipment, buyers should confirm:
- Batch-specific COA.
- Packing list.
- Commercial invoice.
- Storage and handling statement.
- Label or packaging information where applicable.
For broader documentation review, see WUMO's research-grade peptide shipment documents checklist.
What documentation does not guarantee
Documentation supports supplier evaluation and shipment review. It does not guarantee import clearance, registration, sale permission, or approval in any destination market. Buyers remain responsible for destination-market compliance and downstream channel obligations.
Red Flags Buyers Should Watch For
A red flag does not always mean a supplier is unusable. It means the buyer should slow down and clarify.
Documentation red flags
Watch for:
- Supplier cannot define the exact sequence.
- COA without batch number.
- HPLC purity number without chromatogram.
- LC-MS unavailable or unexplained for sequence-sensitive review.
- SDS not available at inquiry stage.
- Specification sheet unavailable.
- Product label used in place of a technical specification sheet.
- TB-500 and related sequence names used interchangeably without clarification.
- Generic documents reused across multiple batches.
A low price with weak documentation is not a strong quote. It is an incomplete quote.
Quote and pricing red flags
Common pricing red flags include:
- Quote issued without sequence confirmation.
- Quote unit not stated.
- USD/vial quote without fill amount.
- USD/box quote without vials per box.
- MOQ given as one number with no basis.
- Lead time stated without scope.
- Documentation scope not listed.
- Price appears attractive but testing, packaging, or documentation is excluded.
The quote should tell the buyer what is included and what is not included. If the buyer has to guess, the quote is not ready for final comparison.
Supplier response red flags
Supplier communication can reveal process maturity.
Watch for:
- Generic catalog reply that does not address sequence.
- No answer on stock vs. made-to-order.
- No explanation of MOQ basis.
- Lead time stated as one number without scope.
- No clear path for document review.
- Custom fill discussed without asking for fill amount or project scope.
- No technical or QC support available when needed.
A stronger supplier usually asks clarifying questions before issuing a formal quotation.
Bulk Powder vs. Lyophilized Vial: Choosing the Right Format
Format choice should follow project stage, quantity, documentation needs, and downstream capability.
Bulk powder
Bulk powder may make sense when:
- The buyer has downstream processing or filling capability.
- The buyer wants material cost separated from vialing and packaging cost.
- The sourcing comparison is made at gram or milligram level.
- The buyer is building inventory for later processing or packaging.
- The project may later move into custom vial discussion.
Bulk powder quotes are usually stated in USD/g or USD/mg. Buyers should confirm net weight, salt form where relevant, purity threshold, documentation scope, and packaging format.
Lyophilized vial
Lyophilized vial format may be suitable when the buyer needs a defined vial-based project format.
Important variables include:
- Fill amount per vial.
- Vial size.
- Vial component.
- Label scope.
- Box configuration.
- Documentation package.
- MOQ.
- Lead time.
- Quote unit.
A vial price is not meaningful without fill amount. A box price is not meaningful without vial count and contents.
For broader vial project scoping, see WUMO's lyophilized peptide vial sourcing guide.
Format selection considerations
Bulk powder and lyophilized vial formats are not directly comparable unless the buyer separates material cost, filling cost, packaging, documentation, and shipment scope.
Both formats require clear documentation. The difference is not whether documentation matters; the difference is which additional packaging, fill, and labeling variables must be defined.
MOQ and Lead Time: What the Numbers Actually Mean
MOQ and lead time should be interpreted by project type, not as isolated numbers.
MOQ factors
An MOQ may be based on:
- Existing stock.
- New synthesis batch.
- Minimum order value.
- Vial filling setup.
- Packaging procurement.
- Custom label or box requirements.
- Documentation workload.
For TB-500 / TB-500 Fragment, buyers should ask whether the MOQ applies to existing material, a new batch, catalog vials, or a custom fill run.
A “100 vials” MOQ means little without knowing fill amount per vial and total material requirement.
Lead time factors
A lead time such as “2–4 weeks” is not enough unless the scope is defined.
Buyers should ask whether it includes:
- Material availability or synthesis.
- QC testing.
- Documentation preparation.
- Vial filling or lyophilization where applicable.
- Packaging.
- Export preparation.
- Dispatch.
- Shipping.
Freight transit time is separate from production lead time. Documentation preparation may also add time after production is complete.
For broader MOQ and lead time review, see WUMO's bulk peptide purchasing guide.
How to Prepare a Stronger RFQ for TB-500
A stronger RFQ reduces back-and-forth and helps suppliers provide comparable quotes.
What most RFQs are missing
Many weak RFQs omit:
- Exact sequence or CAS reference.
- TB-500 vs. TB-500 Fragment clarification.
- Format: bulk powder or lyophilized vial.
- Purity threshold.
- Salt form or counterion where relevant.
- Documentation scope.
- MOQ expectation.
- Destination country.
- Project timeline.
- Preferred quote unit.
When these fields are missing, suppliers either guess or quote against their own default product definition.
Stronger RFQ checklist
A stronger RFQ should include:
- Exact product name and sequence reference.
- CAS number where applicable.
- Requested format.
- Target quantity or fill amount.
- Preferred quote basis: USD/g, USD/mg, USD/vial, or USD/box.
- Purity threshold and analytical method.
- Required documents: COA, HPLC, LC-MS, SDS, specification sheet.
- Packaging or labeling requirements.
- Destination country or shipment region.
- Target timeline.
- Whether NDA is required for custom project discussion.
For quote unit review, see WUMO's Peptide Quote Units guide.
Supplier Qualification Checkpoints for TB-500 Projects
Supplier qualification should evaluate both product documentation and project capability.
Useful checkpoints include:
- Supplier can confirm exact sequence and product definition.
- Specification sheet is available before formal quotation.
- Batch-specific COA is available.
- HPLC chromatogram supports the purity result.
- LC-MS or mass confirmation is available where requested.
- SDS is available at inquiry stage.
- Salt form or counterion is stated where applicable.
- Batch number links to COA and test records.
- MOQ is confirmed in writing with basis explained.
- Lead time is stated with clear scope.
- Supplier reviews buyer specification before issuing quotation.
- Custom fill or private label capability is confirmed if relevant.
For a broader supplier review framework, see WUMO's peptide supplier qualification checklist.
What WUMO Reviews Before Issuing a Formal Quotation
WUMO prefers to clarify project scope before issuing a formal quotation. This helps avoid quoting the wrong material definition, format, unit, documentation scope, or MOQ basis.
For TB-500 / TB-500 Fragment project discussions, WUMO may review:
- Exact product name and sequence reference.
- Required format: bulk powder, vial, or custom fill.
- Target quantity.
- Quote unit preference.
- Fill amount if vial format is requested.
- Documentation scope.
- Batch traceability requirements.
- Packaging and label scope.
- MOQ and lead time expectations.
- Destination-market shipment considerations.
- Whether NDA is needed before detailed discussion.
WUMO does not rely on auto-generated quotes for specification-sensitive peptide projects. A useful quotation starts with product definition and project fit.
How WUMO Supports Qualified TB-500 B2B Sourcing Projects
WUMO supports qualified B2B buyers with TB-500 / TB-500 Fragment sourcing discussion, specification review, documentation review, and project quotation support.
For TB-500 / TB-500 Fragment projects, WUMO can help buyers clarify:
- Bulk powder or lyophilized vial format.
- Product naming and sequence reference.
- Documentation scope.
- COA, HPLC, LC-MS, SDS, and specification sheet availability.
- MOQ and volume tier discussion.
- Lead time assumptions.
- Quote basis.
- Custom fill feasibility.
- Neutral label or private label discussion.
- Packaging scope.
- Project fit before formal quotation.
Availability may vary by batch, project type, destination requirement, and buyer specification. Buyers are encouraged to state product definition, format, documentation, MOQ, and packaging requirements before quotation so the project can be reviewed properly.
Frequently Asked Questions
What is the difference between TB-500 and TB-500 Fragment in a B2B sourcing context?
The difference depends on the exact sequence reference used by the supplier. Buyers should not rely on the name alone. They should confirm sequence, CAS reference where applicable, molecular weight, and documentation scope before comparing quotes.
How do I confirm the correct CAS number for TB-500 before issuing an RFQ?
Ask the supplier to provide a specification sheet that states the exact product name, sequence reference, CAS number where applicable, molecular formula, and molecular weight. The same information should align with the COA and analytical reports.
What documentation should I request when sourcing TB-500 from a supplier?
Common documents may include batch-specific COA, HPLC report, LC-MS or mass confirmation where available, SDS, specification sheet, packing list, commercial invoice, storage statement, and batch number reference.
Why is LC-MS important for TB-500 specification verification?
LC-MS or mass confirmation helps support molecular identity review. It is useful when product naming or sequence reference may vary across suppliers.
What is the typical MOQ for TB-500 in bulk powder vs. lyophilized vial format?
MOQ varies by supplier, product form, fill amount, packaging scope, and whether the item is in stock or made to order. Buyers should request volume tiers and a clear MOQ basis before comparing suppliers.
How is TB-500 purity measured and what threshold should I specify?
Purity is commonly discussed through HPLC, but the buyer should confirm the method, threshold, and whether the report is batch-specific. The required threshold should be defined in the specification sheet.
What is the salt form of TB-500 and why does it matter for sourcing?
Salt form or counterion may affect molecular weight reference, content comparison, and quote evaluation. Buyers should confirm the form stated in the supplier specification and COA before comparing quotes.
What are common red flags when evaluating TB-500 suppliers?
Red flags include unclear sequence, COA without batch number, purity claim without HPLC support, no LC-MS option, undefined MOQ basis, lead time without scope, and documentation only available after payment.
How should I prepare an RFQ for a TB-500 lyophilized vial project?
A strong RFQ should include sequence reference, requested format, fill amount, vial count or box format, purity threshold, documentation requirements, quote unit, destination country, and target timeline.
What storage and shipment conditions apply to TB-500 bulk powder or vials?
Storage and shipment conditions should be confirmed from the supplier's specification sheet, label, and shipment documentation. Many peptide materials may require controlled storage and shipment planning, but exact requirements should be batch and supplier specific.
What quote unit basis should I use when comparing TB-500 supplier quotes?
Use a consistent basis such as USD/mg or USD/g of peptide content, then review packaging, vial fill amount, documentation, MOQ, and shipment scope separately.
Does receiving a COA and HPLC report guarantee import clearance for TB-500?
No. COA and HPLC documents support sourcing review, but they do not guarantee import clearance, regulatory approval, sale permission, or downstream compliance in any destination market.
CTA
If you are evaluating TB-500 or TB-500 Fragment as a B2B sourcing project, WUMO can review your specification, confirm available documentation, and discuss format options, MOQ, and project fit before issuing a formal quotation.
Qualified B2B buyers are welcome to submit a project inquiry with product definition, preferred format, quantity, quote unit, and documentation requirements.
Start a Project Discussion →